Related references
Note: Only part of the references are listed.mTOR Complex 2 Is Required for the Development of Prostate Cancer Induced by Pten Loss in Mice
David A. Guertin et al.
CANCER CELL (2009)
TORC-Specific Phosphorylation of Mammalian Target of Rapamycin (mTOR): Phospho-Ser2481 Is a Marker for Intact mTOR Signaling Complex 2
Jeremy Copp et al.
CANCER RESEARCH (2009)
PIKKing on PKB: regulation of PKB activity by phosphorylation
Lana Bozulic et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
The role of the Birt-Hogg-Dube protein in mTOR activation and renal tumorigenesis
T. R. Hartman et al.
ONCOGENE (2009)
LKB1 regulates polarity remodeling and adherens junction formation in the Drosophila eye
Nancy Amin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C
Valeria Facchinetti et al.
EMBO JOURNAL (2008)
Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys
Masaya Baba et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Interaction of folliculin (Birt-Hogg-Dube gene product) with a novel Fnip1-like (FnipL/Fnip2) protein
Y. Takagi et al.
ONCOGENE (2008)
Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal Neoplasia
Jindong Chen et al.
PLOS ONE (2008)
Mouse Ripply2 is downstream of Wnt3a and is dynamically expressed during somitogenesis
Kristin K. Biris et al.
DEVELOPMENTAL DYNAMICS (2007)
Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling
Masaya Baba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
mTOR and cancer: insights into a complex relationship
David M. Sabatini
NATURE REVIEWS CANCER (2006)
High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dube-associated renal tumors
CD Vocke et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Dysregulation of the TSC-mTOR pathway in human disease
K Inoki et al.
NATURE GENETICS (2005)
A germ-line insertion in the Birt-Hogg-Dube (BHD) gene gives rise to the Nihon rat model of inherited renal cancer
K Okimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The LKB1 tumor suppressor negatively regulates mTOR signaling
RJ Shaw et al.
CANCER CELL (2004)
Renal tumors in the Birt-Hogg-Dube syndrome
CP Pavlovich et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome
ML Nickerson et al.
CANCER CELL (2002)
Share Paper
